Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02387931 · ClinicalTrials.gov registry record · Phase 4
Supplementation in Adolescent Girls With Endometriosis
A Phase 4 study of Endometriosis, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 69
- Enrollment target
- 1
- Study location
NCT02387931: Completed Phase 4 study of Endometriosis, sponsored by Boston Children's Hospital.
NCT02387931 is a Phase 4 study of Endometriosis that has completed, run by Boston Children's Hospital. The registered enrollment target is 69 participants, below the 263-participant average among 48 other Endometriosis trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02387931, a Phase 4 study of Endometriosis, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether dietary supplementation with Vitamin D or Fish Oil can help to reduce physical and emotional symptoms in adolescent girls with endometriosis.
Primary Outcome
Measured by change in the score of the visual analog scale (VAS) from baseline to 6 months.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Vitamin D3
- DIETARY_SUPPLEMENT Fish Oil
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-07 |
| Phase | Phase 4 |
What the finished NCT02387931 record still lists
NCT02387931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 263-participant average among 48 other Endometriosis trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Endometriosis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02387931 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02387931 about?
NCT02387931 is a clinical study titled "Supplementation in Adolescent Girls With Endometriosis". The purpose of this study is to determine whether dietary supplementation with Vitamin D or Fish Oil can help to reduce physical and emotional symptoms in adolescent girls with endometriosis.
What is the current status of trial NCT02387931?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 69 participants. The study started on 2014-09. Estimated completion is 2016-07.
What conditions does trial NCT02387931 study?
This clinical trial studies the following conditions: Endometriosis.
What interventions are being tested in trial NCT02387931?
The interventions under investigation include: Placebo (OTHER), Vitamin D3 (DIETARY_SUPPLEMENT), Fish Oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02387931?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02387931 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02387931's enrollment target sits among peer trials
69 33rd of 48 higher than 16 of 48 other Endometriosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometriosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Thromboxane Function in Women With Endometriosis
RECRUITING · Phase 4
-
Superior Hypogastric Nerve Plexus Block With Bupivacaine After Robotic Resection of Endometriosis
RECRUITING · Phase 4
-
Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee
RECRUITING · Phase 4
-
The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery
ACTIVE NOT RECRUITING · Phase 4
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
COMPLETED · Phase 4
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia